• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人生长激素治疗垂体性侏儒症患儿外周血淋巴细胞的反应性(作者译)

[Reactivity of peripheral blood lymphocytes in children with pituitary dwarfism treated with human growth hormone (author's transl)].

作者信息

Kunicka A, Lenartowska I, Sielicka M

出版信息

Probl Med Wieku Rozwoj. 1975;5:155-60.

PMID:1223865
Abstract

The study has aimed at investigating the blastic transformation of peripheral blood lymphocytes in patients with pituitary dwarfism before, during and after the treatment with human growth hormone. The reactivity of lymphocytes in vitro was studied in cultures stimulated with phytohemagglutinin-M of the Difco Company (PHA), in cultures stimulated with human growth hormone (HGH), and in cultures non-stimulated in vitro. The investigations were carried out in 34 patients with pituitary dwarfism at the age of 7 to 19 years. The control group was made up of 16 healthy children, 8 to 15 years old who had never been administered HGH. The patients were divided into groups according to the circumstance whether it was the first or the subsequent contact with HGH, and according to the periods at which the blood samples were collected during after therapy. It was found that the capability of lymphocytes to blastic transformation after stimulation with a specific stimulus (HGH) in patients with pituitary dwarfism in comparison with the reaction of healthy children is reduced (Fig. 2). The ability of the transformation of lymphocytes in this case shows selectivity towards the stimulus because the inhibiting of the response was noted only after the stimulation with HGH, but not after stimulation with PHA. During the treatment with HGH, allergization of the body appears; this is evidenced by the increase in the percentage of blastic cells in autotransformation (Fig. 1).

摘要

该研究旨在调查垂体性侏儒症患者在使用人生长激素治疗前、治疗期间及治疗后的外周血淋巴细胞的原始细胞转化情况。在由Difco公司的植物血凝素-M(PHA)刺激的培养物、由人生长激素(HGH)刺激的培养物以及未进行体外刺激的培养物中,研究了淋巴细胞在体外的反应性。对34名7至19岁的垂体性侏儒症患者进行了调查。对照组由16名8至15岁从未使用过HGH的健康儿童组成。根据患者是首次还是再次接触HGH的情况,以及在治疗后采集血样的时期,将患者分成不同组。结果发现,与健康儿童的反应相比,垂体性侏儒症患者在受到特定刺激(HGH)后淋巴细胞的原始细胞转化能力降低(图2)。在这种情况下,淋巴细胞的转化能力对刺激具有选择性,因为仅在受到HGH刺激后才观察到反应受到抑制,而在受到PHA刺激后则未观察到。在使用HGH治疗期间,机体出现过敏反应;这可通过自身转化中原始细胞百分比的增加得到证明(图1)。

相似文献

1
[Reactivity of peripheral blood lymphocytes in children with pituitary dwarfism treated with human growth hormone (author's transl)].人生长激素治疗垂体性侏儒症患儿外周血淋巴细胞的反应性(作者译)
Probl Med Wieku Rozwoj. 1975;5:155-60.
2
The results of treatment of pituitary dwarfism with human growth hormone (author's transl).人生长激素治疗垂体性侏儒症的结果(作者译)
Probl Med Wieku Rozwoj. 1972;1:111-9.
3
[Final results of treatment with human growth hormone].[人生长激素治疗的最终结果]
Arch Fr Pediatr. 1984 Aug-Sep;41(7):477-82.
4
[Serial evaluation of blood polyamines in children treated with growth hormone].[生长激素治疗儿童血多胺的系列评估]
Ateneo Parmense Acta Biomed. 1979;50(1):59-67.
5
Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism?重组人生长激素替代疗法与生长激素缺乏症儿童的下丘脑-垂体-甲状腺轴:何时应关注中枢性甲状腺功能减退的发生?
Clin Endocrinol (Oxf). 2003 Dec;59(6):806-10. doi: 10.1046/j.1365-2265.2003.01892.x.
6
Biosynthetic human growth hormone: effects on growth of Snell dwarf mice.生物合成人生长激素:对斯内尔侏儒小鼠生长的影响
Horm Metab Res. 1985 Jan;17(1):20-4. doi: 10.1055/s-2007-1013437.
7
[Dynamics of the bio-electric activity of brain in patients with pituitary dwarfism during the treatment with human growth hormone (author's transl)].
Probl Med Wieku Rozwoj. 1972;1:131-45.
8
[Therapy of pituitary dwarfism with recombinant human growth hormone. A multicenter study].[重组人生长激素治疗垂体性侏儒症。一项多中心研究]
Dtsch Med Wochenschr. 1986 Mar 28;111(13):483-9. doi: 10.1055/s-2008-1068477.
9
Results of four years of intermittent human growth hormone (hGH) and fluoxymesterone therapy in hypopituitary dwarfism.垂体功能减退性侏儒症患者接受四年间歇性人生长激素(hGH)和氟甲睾酮治疗的结果。
Pediatrics. 1980 Mar;65(3):562-6.
10
[Treatment of pituitary dwarfism with human somatotropin].[用人生长激素治疗垂体性侏儒症]
Wien Klin Wochenschr. 1971 Sep 24;83(38):665-8.